Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Pilon

Showing results (41-50 of 79) with videos related to

Pageof 8
Sort By:
Chemotherapy|April 29, 1998
Paclitaxel is an effective antiproliferative agent on the human NCI-H295 adrenocortical carcinoma cell lineF Fallo, C Pilon, L Barzon, et al.
Endocrine Research|November 1, 1996
Effects of taxol on the human NCI-H295 adrenocortical carcinoma cell lineF Fallo, C Pilon, L Barzon, et al.
Hypertension (Dallas, Tex. : 1979)|March 18, 2000
CYP11B2 gene polymorphisms in idiopathic hyperaldosteronismP Mulatero, D Schiavone, F Fallo, et al.
Clinical Neuropharmacology|January 1, 1992
The dopamine D3 receptor as a key target for antipsychoticsP Sokoloff, D Levesque, M P Martres, et al.
European Journal of Pharmacology|July 15, 1994
Functional coupling of the human dopamine D3 receptor in a transfected NG 108-15 neuroblastoma-glioma hybrid cell lineC Pilon, D Lévesque, V Dimitriadou, et al.
The Journal of Clinical Endocrinology and Metabolism|November 24, 1999
Mutations in CYP11B1 gene converting 11beta-hydroxylase into an aldosterone-producing enzyme are not present in aldosterone-producing adenomasC Pilon, P Mulatero, L Barzon, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 11, 2000
Dopamine D3 receptors expressed by all mesencephalic dopamine neuronsJ Diaz, C Pilon, B Le Foll, et al.
Bulletin De L'Academie Nationale De Medecine|June 1, 1988
[Lipoprotein lipase (LPL): recall of the structure of LPL and first results obtained in the isolation of clones from human and rat genomic banks]J Etienne, J C Chuat, S Guilhot, et al.
Comptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales|April 2, 1999
[Function and therapeutic potential of the dopamine D3 receptor]P Sokoloff, J Diaz, R Bordet, et al.
The Journal of Clinical Endocrinology and Metabolism|June 8, 2004
Changes in muscle myostatin expression in obese subjects after weight lossG Milan, E Dalla Nora, C Pilon, et al.
Pageof 8

Showing results (41-50 of 79) with videos related to

Sort By:
Pageof 8
Chemotherapy|April 29, 1998
Paclitaxel is an effective antiproliferative agent on the human NCI-H295 adrenocortical carcinoma cell lineF Fallo, C Pilon, L Barzon, et al.
Endocrine Research|November 1, 1996
Effects of taxol on the human NCI-H295 adrenocortical carcinoma cell lineF Fallo, C Pilon, L Barzon, et al.
Hypertension (Dallas, Tex. : 1979)|March 18, 2000
CYP11B2 gene polymorphisms in idiopathic hyperaldosteronismP Mulatero, D Schiavone, F Fallo, et al.
Clinical Neuropharmacology|January 1, 1992
The dopamine D3 receptor as a key target for antipsychoticsP Sokoloff, D Levesque, M P Martres, et al.
European Journal of Pharmacology|July 15, 1994
Functional coupling of the human dopamine D3 receptor in a transfected NG 108-15 neuroblastoma-glioma hybrid cell lineC Pilon, D Lévesque, V Dimitriadou, et al.
The Journal of Clinical Endocrinology and Metabolism|November 24, 1999
Mutations in CYP11B1 gene converting 11beta-hydroxylase into an aldosterone-producing enzyme are not present in aldosterone-producing adenomasC Pilon, P Mulatero, L Barzon, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 11, 2000
Dopamine D3 receptors expressed by all mesencephalic dopamine neuronsJ Diaz, C Pilon, B Le Foll, et al.
Bulletin De L'Academie Nationale De Medecine|June 1, 1988
[Lipoprotein lipase (LPL): recall of the structure of LPL and first results obtained in the isolation of clones from human and rat genomic banks]J Etienne, J C Chuat, S Guilhot, et al.
Comptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales|April 2, 1999
[Function and therapeutic potential of the dopamine D3 receptor]P Sokoloff, J Diaz, R Bordet, et al.
The Journal of Clinical Endocrinology and Metabolism|June 8, 2004
Changes in muscle myostatin expression in obese subjects after weight lossG Milan, E Dalla Nora, C Pilon, et al.
Pageof 8